BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-809@pharmaconomics
DTSTAMP:20260707T033824Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:ELTX AdCom — ELI-002 7P (estimated date)
DESCRIPTION:An FDA advisory committee reviews ELI-002 7P for metastatic mKRAS pancreatic cancer around ~ Jun 30\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1601485/000160148526000046/a8k-deckconferencecallfi.htm\n\nTrack it: https://pharmaconomics.com/e/809
URL:https://pharmaconomics.com/e/809
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ELTX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR